OptimizeRx (OPRX) Receivables Refunds (2023 - 2025)
OptimizeRx (OPRX) has disclosed Receivables Refunds for 3 consecutive years, with $752000.0 as the latest value for Q4 2025.
- Quarterly Receivables Refunds changed N/A to $752000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $752000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $752000.0 for FY2025, N/A changed from the prior year.
- Receivables Refunds hit $752000.0 in Q4 2025 for OptimizeRx, down from $1.7 million in the prior quarter.
- In the past five years, Receivables Refunds ranged from a high of $1.8 million in Q2 2024 to a low of $64000.0 in Q3 2024.
- Historically, Receivables Refunds has averaged $904500.0 across 3 years, with a median of $894000.0 in 2023.
- Biggest YoY gain for Receivables Refunds was 2629.69% in 2025; the steepest drop was 89.09% in 2025.
- Year by year, Receivables Refunds stood at $1.0 million in 2023, then tumbled by 93.82% to $64000.0 in 2024, then surged by 1075.0% to $752000.0 in 2025.
- Business Quant data shows Receivables Refunds for OPRX at $752000.0 in Q4 2025, $1.7 million in Q3 2025, and $646000.0 in Q2 2025.